Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candida skin-test response in diabetic polyneuropathy and Charcot neuro-osteoarthropathy
NL-OMON36125Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of candida albicans antigen in diabetic polyneuropathy (DPN) and Charcot neuroarthropathy (CN) (4 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Extent of induration after intracutaneous Candida albicans extract. Started May 2012; status: active, not recruiting.
02
Drugs
candida albicans antigen
03
Conditions
diabetic polyneuropathy (DPN)Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on NL-OMON36125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36125.